Targeted disruption of serine racemase affects glutamatergic neurotransmission and behavior
Tóm tắt
Từ khóa
Tài liệu tham khảo
Johnson JW, Ascher P . Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 1987; 325: 529–531.
Kleckner NW, Dingledine R . Requirement for glycine in activation of NMDA receptors expressed in Xenopus oocytes. Science 1988; 241: 835–837.
Fadda E, Danysz W, Wroblewski JT, Costa E . Glycine and D-serine increase the affinity of N-methyl-D-aspartate sensitive glutamate binding sites in rat brain synaptic membranes. Neuropharmacology 1988; 27: 1183–1185.
Matsui T, Sekiguchi M, Hashimoto A, Tomita U, Nishikawa T, Wada K . Functional comparison of D-serine and glycine in rodents: the effect on cloned NMDA receptors and the extracellular concentration. J Neurochem 1995; 65: 454–458.
Mothet JP, Parent AT, Wolosker H, Brady Jr RO, Linden DJ, Ferris CD et al. -Serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor. Proc Natl Acad Sci USA 2000; 97: 4926–4931.
Gustafson EC, Stevens ER, Wolosker H, Miller RF . Endogenous D-serine contributes to NMDA-receptor-mediated light-evoked responses in the vertebrate retina. J Neurophysiol 2007; 98: 122–130.
Panatier A, Theodosis DT, Mothet JP, Touquet B, Pollegioni L, Poulain DA et al. Glia-derived D-serine controls NMDA receptor activity and synaptic memory. Cell 2006; 125: 775–784.
Hashimoto A, Nishikawa T, Oka T, Takahashi K . Endogenous D-serine in rat brain: N-methyl-D-aspartate receptor-related distribution and aging. J Neurochem 1993; 60: 783–786.
Schell MJ, Molliver ME, Snyder SH . -Serine, an endogenous synaptic modulator: localization to astrocytes and glutamate-stimulated release. Proc Natl Acad Sci USA 1995; 92: 3948–3952.
Wolosker H, Sheth KN, Takahashi M, Mothet JP, Brady Jr RO, Ferris CD et al. Purification of serine racemase: biosynthesis of the neuromodulator D-serine. Proc Natl Acad Sci USA 1999; 96: 721–725.
Wolosker H, Blackshaw S, Snyder SH . Serine racemase: a glial enzyme synthesizing D-serine to regulate glutamate-N-methyl-D-aspartate neurotransmission. Proc Natl Acad Sci USA 1999; 96: 13409–13414.
Coyle JT . Glutamate and schizophrenia: beyond the dopamine hypothesis. Cell Mol Neurobiol 2006; 26: 365–384.
Morita Y, Ujike H, Tanaka Y, Otani K, Kishimoto M, Morio A et al. A genetic variant of the serine racemase gene is associated with schizophrenia. Biol Psychiatry 2007; 61: 1200–1203.
Chumakov I, Blumenfeld M, Guerassimenko O, Cavarec L, Palicio M, Abderrahim H et al. Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proc Natl Acad Sci USA 2002; 99: 13675–13680.
Schumacher J, Abon Jamra A, Freudenberg J, Becker T, Ohlraun S et al. Examination of G72 and D-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder. Mol Psychiatry 2004; 9: 203–207.
Detera-Wadleigh SD, McMahon FJ . G72/G30 in schizophrenia and bipolar disorder: review and meta-analysis. Biol Psychiatry 2006; 60: 106–114.
Shi J, Badner JA, Gershon ES, Liu C . Allelic association of G72/G30 with schizophrenia and bipolar disorder: a comprehensive meta-analysis. Schizophr Res 2008; 98: 89–97.
Hashimoto K, Fukushima T, Shimizu E, Komatsu N, Watanabe H, Shinoda N et al. Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia. Arch Gen Psychiatry 2003; 60: 572–576.
Bendikov I, Nadri C, Amar S, Panizzutti R, De Miranda J, Wolosker H et al. A CSF and postmortem brain study of D-serine metabolic parameters in schizophrenia. Schizophr Res 2006; 90: 41–51.
Tsai G, Yang P, Chung L, Lange N, Coyle JT . -Serine added to antipsychotics for the treatment of schizophrenia. Biol Psychiatry 1998; 44: 1081–1089.
Lane H, Chang Y, Liu Y, Chiu C, Tsai GE . Sarcosine or D-serine add-on treatment for acute exacerbation of schizophrenia. Arch Gen Psychiatry 2005; 62: 1196–1204.
Heresco-Levy U, Javitt DC, Ebstein R, Vass A, Lichtenberg P et al. D-Serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia. Biol Psychiatry 2005; 57: 577–585.
Tsai GE, Yang P, Chung L, Tsai I, Tsai C, Coyle JT . D-Serine added to clozapine for the treatment of schizophrenia. Am J Psychiatry 1999; 156: 1822–1825.
Kartvelishvily E, Shleper M, Balan L, Dumin E, Wolosker H . Neuron-derived D-serine release provides a novel means to activate N-methyl-D-aspartate receptors. J Biol Chem 2006; 281: 14151–14162.
Hashimoto A, Nishikawa T, Oka T, Takahashi K, Hayashi T . Determination of free amino acid enantiomers in rat brain and serum by high-performance liquid chromatography after derivatization with N-tert-butyloxycarbonyl-L-cysteine and o-phthaldialdehyde. J Chromatogr 1992; 582: 41–48.
Jaffrey SR, Snyder SH . The biotin switch method for the detection of S-nitrosylated proteins. Sci STKE 2001; 86: PL1.
Chen HX, Otmakhov N, Lisman J . Requirements for LTP induction by pairing in hippocampal CA1 pyramidal cells. J Neurophysiol 1999; 82: 526–532.
Martina M, Krasteniakov NV, Bergeron R . -Serine differently modulates NMDA receptor function in rat CA1 hippocampal pyramidal cells and interneurons. J Physiol 2003; 548 (Part 2): 411–423.
Chen L, Muhlhauser M, Yang CR . Glycine tranporter-1 blockade potentiates NMDA-mediated responses in rat prefrontal cortical neurons in vitro and in vivo. J Neurophysiol 2003; 89: 691–703.
Bredt DS, Snyder SH . Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA 1990; 87: 682–685.
Stamler JS, Simon DI, Osborne JA, Mullins ME, Jaraki O, Michel T et al. S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc Natl Acad Sci USA 1992; 89: 444–448.
Schell MJ, Brady Jr RO, Molliver ME, Snyder SH . -Serine as a neuromodulator: regional and developmental localizations in rat brain glia resemble NMDA receptors. J Neurosci 1997; 17: 1604–1615.
Cadenhead KS, Swerdlow NR, Shafer KM, Diaz M, Braff DL . Modulation of the startle response and startle laterality in relatives of schizophrenic patients and in subjects with schizotypal personality disorder: evidence of inhibitory deficits. Am J Psychiatry 2000; 157: 1660–1668.
Plappert CF, Rodenbücher AM, Pilz PK . Effects of sex and estrous cycle on modulation of the acoustic startle response in mice. Physiol Behav 2005; 84: 585–594.
Walker DL, Davis M . Anxiogenic effects of high illumination levels assessed with the acoustic startle response in rats. Biol Psychiatry 1997; 42: 461–471.
Davis M, Ressler K, Rothbaum BO, Richardson R . Effects of D-cycloserine on extinction: translation from preclinical to clinical work. Biol Psychiatry 2006; 60: 369–375.